Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cefalexin 50mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cefalexin 25mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cefalexin monohydrate 333 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cefalexin monohydrate 750 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cefalexin 25 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cefalexin monohydrate 500 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cefalexin monohydrate 250 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cefalexin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cefalexin monohydrate 250 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cefalexin monohydrate 250 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin monohydrate 250 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin monohydrate 500 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin monohydrate 500 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin monohydrate 250 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin monohydrate 250 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin monohydrate 333 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin monohydrate 333 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin monohydrate 750 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin monohydrate 750 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin monohydrate 750 milligram/1 each conventional release oral capsule |
Has precise active ingredient |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin monohydrate 333 milligram/1 each conventional release oral capsule |
Has precise active ingredient |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin monohydrate 500 milligram/1 each conventional release oral capsule |
Has precise active ingredient |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin monohydrate 250 milligram/1 each conventional release oral capsule |
Has precise active ingredient |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin monohydrate 250 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin (as cefalexin monohydrate) 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin (as cefalexin monohydrate) 500 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin (as cefalexin monohydrate) 250 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
False |
Cefalexin monohydrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |